ACI’s Precision Medicine Congress will bring together senior executives and experts from top Pharma and Biopharma companies, Technology Providers, Research Institutes and leading Academia within the industry to discuss the latest challenges and developments making an impact on the industry.
The 2019 event will take place in Berlin, Germany on the 10th and 11th of April. The conference intends to examine Precision Medicine in depth, with presentations and discussions on key topics such as regulatory compliance, case studies of ongoing trials, the role of Bio-banking as well as examining what the future may hold for an industry with huge potential.
At the event there will be a key focus on collaboration between all sectors of the industry to understand the needs of each stakeholder and identifying how this can be improved in the future. This event will also allow for plenty of time for networking, Q&A’s and open discussion to ensure that all attendees get a chance to put their opinion across and make this Precision Medicine Congress as interactive as possible.
If you would like to be considered as a speaker for the event with a 30-45 minute presentation, please submit an abstract for consideration to:
Tel: +44 (0)20 3141 0649
Email: [email protected]
If you would like to be know more about some of the sponsorship or commercial opportunities available at the conference please contact:
Tel: +91 20 48 523 141
Email: [email protected]
Micha was born 1964 in Geneva, Switzerland, and studied medicine in Heidelberg and Paris, he earned his “Dr.” in Immunology at the German Cancer Research Center (DKFZ) and the Institute of Immunology of the Ruprecht-Karls-University Heidelberg. At the Christian-Albrechts-University of Kiel he earned an Master of Hospital Management; since 2017 Founder of the Precision Medicine Alliance GmbH, since 2018 Medical Director of the Xpomet Medicinale Berlin, former Medical Director Business Development (EMEA) of Molecular Health GmbH, Heidelberg; previously Assistant to the CEO of Unfallkrankenhaus Berlin, M & A Manager for the Marseille-Kliniken AG for the CEO and over 10 years professional experience in strategic and operative hospital management consulting, e.g. the Alerion Group AG, Planungsgruppe M+M AG and Lohfert & Lohfert AG. Before Micha practiced in clinical Oncology, Haematologie & Bown-Marrow-Transplantation. Micha is since 2003 the Founder and Chairman of the non-for-profit think-tank SUENJHAID! The Health Captains – Networking fort he future of value-based Health Sciences Business, based on the Island of Foehr in the North Sea.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.Link: http://www.pharmavoice.com
Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, written by experts in their respective fields and cover all aspects of drug discovery from state-of-the-art genomic and proteomic approaches to target identification, through the most innovative computational approaches drug design, the science driving medicinal chemistry and the translation of these sciences to therapies.
Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals. The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ – the global brand for the industry.
BioChem Adda aims to provide the most reliable information portal related to biotech jobs, biotech internships, careers, education, fellowships, news, articles, and events from the field of Biological and Chemical Sciences!
Chemicals Knowledge Hub was founded to provide a rapid-publication service to the speciality chemicals industry. Covering pharmaceuticals and cosmetics to agrochemicals and polymers, contract manufacturing to chemical regulations, and always with an eye on sustainability and corporate responsibility, this fast-growing, ever-evolving industry needs a one-stop site that provides up-to-date news and reviews from key opinion leaders and captains of industry. If you develop, manufacture, distribute, use or regulate chemical products that provide qualities or effects on which other industry sectors rely, this site is relevant to you.
pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.
Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.
GBI has offices in Shanghai, Beijing, and Washington D.C.
THE PHARMA WORLD is the first and the only bi-monthly Pharmaceutical and Health Journal of its kind in Bangladesh catering to the needs of Pharmaceutical Industries, Physicians, Healthcare Providers and all other stakeholders related to this sector for the last 12 years. The Journal is also designed to disseminate information about the advancement of research & development in pharmaceutical sector and medical science, thereby, constantly updating readers on this multi-dimensional segment.
THE PHARMA WORLD also has a Consultancy Division which is engaged in a wide range of activities which include Export Promotion, Bioequivalence Study, Market Survey, Training, and organizing Seminar/Workshop/Conference on matters relating to the pharma sector.
ASD Media is an online media company. We provide professionals in dedicated markets with news, intelligence, and interaction opportunities. During the last five years we developed dedicated websites for events, reports, news distribution and source data, and changed the name of the ASD-Network to ASDNews to emphasize the news focus.
Technology Networks is a global online scientific publication that covers the latest research, industry news, and technologies. Our 12 online communities provide focused coverage of analytical chemistry, life sciences, drug discovery, and neuroscience – enabling researchers to easily find reliable, digestible, and high-quality content on the science that matters to them.
Through our communities, 30+ targeted newsletters, online events, and social media we reach and engage with scientists around the world. We strive to educate, foster ideas, and explore the latest scientific developments in and out of the lab.